These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32187665)

  • 1. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Russo M; Newell JM; Budurlean L; Houser KR; Sheldon K; Kesterson J; Phaeton R; Hossler C; Rosenberg J; DeGraff D; Shuman L; Broach JR; Warrick JI
    Cancer; 2020 Jun; 126(12):2775-2783. PubMed ID: 32187665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.
    Chapel DB; Patil SA; Plagov A; Puranik R; Mendybaeva A; Steinhardt G; Wanjari P; Lastra RR; Kadri S; Segal JP; Ritterhouse LL
    Mod Pathol; 2019 Oct; 32(10):1508-1520. PubMed ID: 31186530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
    Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
    Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma.
    Cun HT; Bernard L; Lande KT; Lawson BC; Nesbakken AJ; Davidson B; Lindemann K; Fellman B; Sørlie T; Soliman PT; Eriksson AGZ
    Gynecol Oncol; 2024 Oct; 189():138-145. PubMed ID: 39126895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
    D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
    Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
    Hussein YR; Weigelt B; Levine DA; Schoolmeester JK; Dao LN; Balzer BL; Liles G; Karlan B; Köbel M; Lee CH; Soslow RA
    Mod Pathol; 2015 Apr; 28(4):505-14. PubMed ID: 25394778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer.
    Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Fambrini M; Petraglia F; Pillozzi S; Noci I
    Oncol Rep; 2019 Mar; 41(3):1560-1574. PubMed ID: 30569174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
    Asaka S; Liu Y; Yu ZC; Rahmanto YS; Ono M; Asaka R; Miyamoto T; Yen TT; Ayhan A; Wang TL; Shih IM
    Mod Pathol; 2023 Feb; 36(2):100045. PubMed ID: 36853791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma.
    Gotoh O; Sugiyama Y; Tonooka A; Kosugi M; Kitaura S; Minegishi R; Sano M; Amino S; Furuya R; Tanaka N; Kaneyasu T; Kumegawa K; Abe A; Nomura H; Takazawa Y; Kanao H; Maruyama R; Noda T; Mori S
    J Pathol; 2024 Jul; 263(3):275-287. PubMed ID: 38734880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of endometrioid carcinoma.
    Albertini AF; Devouassoux-Shisheboran M; Genestie C
    Bull Cancer; 2012 Jan; 99(1):7-12. PubMed ID: 22231875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
    Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
    PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
    Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
    Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin.
    Ono K; Kasajima R; Katayama K; Miyagi Y; Yokose T
    Pathol Int; 2021 Aug; 71(8):491-499. PubMed ID: 34015161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women.
    Gbelcová H; Bakeš P; Priščáková P; Šišovský V; Hojsíková I; Straka Ľ; Konečný M; Markus J; D'Acunto CW; Ruml T; Böhmer D; Danihel Ľ; Repiská V
    Anal Cell Pathol (Amst); 2015; 2015():746856. PubMed ID: 26114084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
    Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.